CK2:瘤免疫微环境中的主调节器 - 瘤治疗中的关键目标
Subhajit Karmakar1, Mouli Chatterjee1, Malini Basu2
1Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), TRUE Campus, CN-6, Sector-V, Salt Lake, Kolkata, 700032, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201002, India; 4, Raja S.C, Mullick Road, Jadavpur, Kolkata, 700032, India.
European journal of pharmacology
|February 14, 2025
概括
素激酶2 (CK2) 的过度表达会在瘤免疫微环境 (TME) 中破坏抗瘤免疫力. 向CK2提供了一个有希望的策略,以提高癌症免疫治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生化学
背景情况:
- 氨酸激酶2 (CK2) 是一种调节重要细胞过程的氨酸/氨酸激酶.
- 在瘤免疫微环境 (TME) 中,CK2在免疫系统调节中发挥着关键作用.
- 过度表达CK2与抑制的抗瘤免疫和瘤免疫逃避有关.
研究的目的:
- 探索向CK2在癌症治疗中的治疗潜力 (瘤疗法).
- 研究CK2通过哪些机制影响TME中的免疫反应.
- 审查CK2在免疫抑制中的作用,以开发新的免疫疗法.
主要方法:
- 文献综述侧重于CK2在瘤发生和免疫调节中的作用.
- 对CK2对免疫检查点标记物,细胞因子释放和免疫抑制细胞 (Tregs,MDSCs) 的影响的分析.
- 检查CK2在TME内对免疫逃避的贡献.
主要成果:
- 过度表达CK2降低了免疫效应细胞的调节,并提高了免疫抑制因素.
- 通过增强免疫检查点和免疫抑制细胞,CK2促进免疫抑制的TME.
- CK2活动对于瘤免疫逃避和抗瘤免疫的抵抗至关重要.
结论:
- 在TME中,CK2是免疫抑制的重要调节者.
- 向CK2是一个可行的治疗策略,可以增强抗瘤免疫力.
- 了解CK2的功能可以提高癌症治疗中的免疫疗法疗效.
相关概念视频
Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
Cytotoxic T Cells-mediated Immune Response
830
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
830
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


